Connect your AI

MiMedx Group MDXG Change in Other Liabilities

Change in Other Liabilities at other companies

IAR

Integra LifeSciencesIART

$369K-73.4%

Organogenesis Holdings Inc.ORGO

$293K—

VericelVCEL

$4K-99.6%

Johnson & JohnsonJNJ

-$629M+90.3%

Orthofix Medical Inc.OFIX

-$5.22M+75.6%

AxogenAXGN

-$1K-102%

Other financials

Income statement

Revenue$59.0M-33.1%

Gross profit$41.6M-41.9%

Operating income-$16.0M-295%

Net income-$10.9M-255%

EPS (diluted)-$0.07-240%

Balance sheet

Cash & equivalents$159.8M+50.1%

Total debt$17.6M-5.7%

Total equity$242.9M+19.8%

Total assets$308.7M+14.1%

Cash flow

Operating cash flow$1.9M-64.5%

CapEx$570.0K+51.2%

Free cash flow$1.3M-73.4%

Valuation

Market cap$567.48M-33.9%

Enterprise value$425.3M-44.8%

P/E18.5×-2.9×

P/S1.5×-1.0×

Profitability

Gross margin81%-0.9pp

Operating margin10.2%-5.1pp

Net margin7.9%-3.5pp

FCF margin17.8%-0.5pp

Returns & leverage

Return on equity13.8%-8.6pp

Debt / equity0.1×0.0×

Current ratio5.4×+0.7×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingLiabilities.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's change in other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is MiMedx Group's change in other liabilities?: MiMedx Group (MDXG) reported change in other liabilities of $250K in Q1 2026.
How has MiMedx Group's change in other liabilities changed year-over-year?: MiMedx Group's change in other liabilities increased by 57.2% year-over-year, from $159K to $250K.
What does change in other liabilities mean?: Change in miscellaneous liabilities affecting operating cash flow.